NDC product
Mirapex ER
NDC 0597-0113 · Boehringer Ingelheim Pharmaceuticals, Inc.
Key facts
| Product NDC | 0597-0113 |
|---|---|
| Proprietary name | Mirapex |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Marketing category | NDA |
| Application number | NDA022421 |
| Marketing start | Feb 22, 2010 |
| Marketing end | Jun 20, 2024 |
| Listing certified through | Jun 20, 2024 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: